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Abstract
Sjögren-Larsson syndrome is a rare autosomal recessive disorder that was originally recognized in the
coexistence of congenital ichthyosis, spastic diplegia or quadriplegia and mental retardation. We
recently saw two cases with characteristic features of this rare syndrome. Two brothers aged 21 and
25 years presented with triad of congenital ichthyosis, mental retardation and spastic diplegia.
Magnetic resonance imaging showed demyelinating disease in one of these cases. Electrodiagnostic
studies were normal in all cases.
Introduction
Sjögren-Larsson syndrome (SLS) is a rare neurocutaneous
disorder. Additional clinical findings have been reported
include characteristic retinopathy, pruritus, preterm birth
andskeletalabnormality[1].SLS isdue toa geneticblockin
the oxidation of fatty alcohol to fatty acid because of
deficientactivityoffattyaldehydedehydrogenase(FALDH).
This enzyme catalyzes the oxidation of long chain fatty
aldehydes to fatty acids. Accumulation of long-chain fatty
alcohols and modification of macromolecules by an excess
of fatty aldehydes are thought to be the pathophysiologic
mechanisms causing the manifestations of SLS [2]. It occurs
in all races and its prevalence has been estimated as 0.4 per
100,000 or lower. Over 200 cases worldwide have been
reported[3].HerewedescribetwocasesinanIranianfamily.
Case presentation
Two brothers aged 21 and 25 years from Iranian family,
presented with generalized dryness of skin since birth and
difficulty in walking since the age of 4-5 years. There was
a history of consanguinity in parents. The parents and
siblings were healthy, but their cousin was affected by self-
report. The younger brother was delivered at full term by
normal vaginal delivery and the elder brother was born
pre-term. Skeletal abnormalities (e.g. short stature,
kyphoscoliosis) were not observed. They were not
performing well at school. Cutaneous examination
revealed generalized dryness of skin with fine scales
most predominant around the umbilicus and in the
flexural folds (Figure 1). Neurological examination
revealed moderate mental retardation in both of them.
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and presented since the age of 5-6 years. Their gait was
spastic with brisk deep tendon reflexes in the lower limbs.
The patients had grade 4/5 power in both lower limbs.
These features were more marked in the younger brother,
as were the cutaneous findings. Upper limbs had normal
power, tone and deep tendon reflexes. There were no
sensory, extrapyramidal or cerebellar signs in our cases.
Sensory exam included test for light touch, superficial
pain, temperature, position sense and vibration. Evalua-
tion of cerebellar function (finger-nose, heel-shin, Rom-
berg test, dysdiadochokinesia) and extrapyramidal exam
(smoothness of motor function) was normal.
Pruritus was an accompanying disabling feature in
patients. Skin biopsy showed orthohyperkeratosis,
acanthosis and papillomatosis. An ocular examination
revealed bilateral Glistening dot on the macular region of
the retina in both of them (Figure 2). In elder brother,
brain MRI revealed dysmyelination in the deep periven-
tricular white matter and reduced brain volume in frontal
lobe (Figure 3). The younger brother had normal brain
MRI. Nerve conduction study and electromyography were
normal in cases. All EEG recordings showed symmetrical
slow background activity without other abnormalities. The
histochemical analysis of hexonal dehydrogenase in skin
and biochemical assay of leukocytes or fibroblasts for
FALDH were not available. The lipid profile was normal.
Discussion
SLS is an inborn error of fatty alcohol oxidation. Very high
prevalence of SLS has been observed in north east of
Sweden where an incident of 8.3:100,000 births has been
reported [4]. However, there are no epidemiological
reports on its frequency in the Iranian population, and
as far as we know, these are the first cases of SLS with
pathognomonic findings in Iran. In our patients, the signs
and symptoms were nonspecific and physicians did not
consider SLS as a diagnosis. The diagnosis of SLS is almost
always delayed because usually only cutaneous symptoms
are present at birth. Newborns usually manifest symptoms
and signs of the disease (first ichthyosis, subsequently
neurologic symptoms). Since the skin disorder is the most
prominent sign in infancy, patients were first seen by
dermatologist and minor neurologic signs were missed.
The diagnosis was made later, when neurologic signs
Figure 1. Photograph of the highly characteristic
abnormalities of the skin.
Figure 2. Fluorescein angiography at the left eye of younger
brother, including macular Glistening dot.
Figure 3. T2-weighted MR images. Signal-intensity changes of
the periventricular white matter with involvement of the
frontal trigones.
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and is more severe in the lower limbs than in other parts of
the body [5]. After neurologic symptoms appear, devel-
opment is progressively delayed. No progression of the
neurologic findings or mental retardation occurs after
puberty. The diagnosis should be considered in all patients
with generalized hyperkeratosis and central nervous
system dysfunction. The presence of glistening dots in
the macular region is considered pathognomonic,
although it is not constant. The nature of the crystalline
deposits in the retina is unclear. It is speculated that they
might represent accumulations of long-chain fatty alco-
hols or fatty aldehydes [6]. This finding was present in our
cases. About 30-60% of patients have convulsion during
infancy. This was not the case in our patients. MR imaging
shows retardation of myelination and dysmyelination.
A clear relationship between the degree of the MRI
abnormality and the neurological features or the age of
patients could not be demonstrated. In SLS, MR imaging
abnormalities of the brain are confined to the cerebral
white matter and the corticospinal tracts. They consist of
the accumulation of lipid substrates, delayed myelination,
periventricular gliosis, and a permanent myelin deficit.
The patterns are strikingly similar among patients with
SLS, but the severity varies [7,9]. The differential diagnosis
of SLS is other neuroichthyotic disorders and confirmed by
the very low level of FALDH activity. However, this test is
not available inour country. The clinical triad of syndrome
eliminates the possibilities of other ichthyosiform ery-
throdermas with neurologic signs. In atypical cases, the
differential diagnosis might encompass peroxisomal dis-
orders (e.g. Refsum disease), and many other rare
syndromes which involve multiple organs [10]. It is useful
to evoke the diagnosis when spastic paraparesis is
associated with unusual cutaneous signs.
Management in SLS is supportive [11]. Topical moisturiz-
ing lotion, keratolytic agents and oral retinoids was
administered as outpatient medications. The daily man-
agement of the ichthyosis was taught. Training to provide
home-based physical therapy is useful to prevent contrac-
tures. Stretching of muscles in lower limbs and aquatic
therapy was administered for patients. Presently, our
patients have no progression of symptoms. Spasticity in
lower limbs has decreased and they have remained
ambulatory without assistance. The elder brother has
married and has a healthy daughter. Also, cutaneous
symptoms were improved after treatment.
Abbreviations
SLS, Sjögren-Larsson syndrome; MRI, magnetic resonance
imaging; FALDH, fatty aldehyde dehydrogenase; EEG,
electroencephalogram.
Consent
Written informed consent was obtained from the patients
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Competing interests
The authors have no competing interests.
Authors’ contributions
The final manuscript as titled ’Sjögren-Larsson Syndrome
in two brothers: a case report’ has been read and approved
by all authors and all authors take responsibility for the
content of the manuscript.
References
1. Willemsen MA, Rotteveel JJ, van Domburg PH, Gabreëls FJ,
Mayatepek E, Sengers RC: Preterm birth in Sjögren-Larsson
syndrome. Neuropediatrics 1999, 30:325-327.
2. Haug S, Braun-Falco M: Restoration of fatty aldehyde dehydro-
genase deficiency in Sjögren-Larsson syndrome. Gene Ther
2006, 13:1021-1026.
3. Richards BW, Rundle A, Wilding A: Congenital ichthyosis, spastic
diplegia and mental deficiency. I Ment Def Res 1957, 1:118-129.
4. Jagell S, Gustavson K-H, Holmgren G: Sjögren-Larsson syndrome
in Sweden: a clinical, genetic and epidemiological study. Clin
Genet 1981, 19:233-256.
5. Carney G, Wei S, Rizzo WB: Sjögren-Larsson syndrome: seven
novel mutations in the fatty aldehyde dehydrogenase gene
ALDH3A2. Hum Mutat 2004, 24:186.
6. Willemsen MA, Cruysberg JR, Rotteveel JJ, Aandekerk AL, van
Domburg PH, Deutman AF: Juvenile macular dystrophy asso-
ciated with deficient activity of fatty aldehyde dehydrogenase
in Sjögren-Larsson syndrome. Am J Ophthalmol 2000, 130:782-
789.
7. Willemsen MA, Van Der Graaf M, Van Der Knaap MS, Heerschap A,
Van Domburg PH, Gabreëls FJ, Rotteveel JJ: MR imaging and
proton MR spectroscopic studies in Sjögren-Larsson syn-
drome: characterization of the leukoencephalopathy. Am J
Neuroradiol 2004, 25:649-657.
8. Nakayama M, Tavora DG, Alvim TC, Araujo AC, Gama RL: MRI and
1H-MRS findings of three patients with Sjögren-Larsson
syndrome. Arq Neuropsiquiatr 2006, 64:398-401.
9. van Domburg PH, Willemsen MA, Rotteveel JJ, de Jong JG,
Thijssen HO, Heerschap A, Cruysberg JR, Wanders RJ, Gabreëls FJ,
Steijlen PM: Sjögren-Larsson Syndrome: Clinical and MRI/MRS
findings in FALDH deficient patients. Neurology 1999, 52:1345-
1352.
10. Rizzo WB: Sjögren-Larsson syndrome. Semin Dermatol 1993,
12:210-218.
11. Sood M, Trehan A, Dinakaran J, Marwaha RK: Sjögren-Larsson
syndrome. Indian J Pediatr 2002, 69:193-194.
Page 3 of 3
(page number not for citation purposes)
Cases Journal 2009, 2:8434 http://casesjournal.com/casesjournal/article/view/8434